March 04, 2011
Article
Ten Questions Every Patient Should be Asking
March 04, 2011
Article
More and more deadly diseases are slowly being transformed into chronic conditions. This is especially true of cancer.
March 04, 2011
Article
The Prostate Cancer Clinical States model was first proposed by Scher and colleagues nearly 10 years ago.
March 04, 2011
Article
Worldwide, there are ~204,000 new cases of ovarian cancer each year, accounting for 4% of cancers diagnosed in women.
March 04, 2011
Article
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality in the United States.
March 04, 2011
Article
Androgen-deprivation therapy (ADT) is a widely accepted treatment for men with advanced or metastatic prostate cancer.
March 04, 2011
Article
The FDA approved Tasigna (nilotinib) as a first-line treatment for patients with newly diagnosed Philadelphia- chromosome positive (Ph ) chronic myeloid leukemia (CML), the first new drug approved for this indication in nearly a decade.
March 04, 2011
Article
The FDA approved the injectable drug Jevtana (cabazitaxel), a microtubule inhibitor, in combination with prednisone as a second-line therapy for men with advanced castrate-resistant prostate cancer
March 04, 2011
Article
In the RADIANT-3 (RAD001 In Advanced Neuroendocrine Tumors) phase III study involving patients with pancreatic neuroendocrine tumors (NET)
March 04, 2011
Article
As 2010 has rolled along, the Intellisphere Oncology Specialty Group has aimed to uphold its mission of Bringing the Oncology Community Together.
March 04, 2011
Article
The landscape for managing prostate cancer is changing rapidly. In recent months, we have seen two new drugs approved for hormone refractory advanced disease